Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Short term Debt (2020 - 2026)

Bioventus filings provide 6 years of Short term Debt readings, the most recent being $11.2 million for Q3 2025.

  • On a quarterly basis, Short term Debt fell 70.83% to $11.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $11.2 million, a 70.83% decrease, with the full-year FY2024 number at $27.3 million, changed N/A from a year prior.
  • Short term Debt hit $11.2 million in Q3 2025 for Bioventus, down from $43.4 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $43.4 million in Q2 2025 to a low of $11.2 million in Q3 2025.
  • Median Short term Debt over the past 5 years was $24.9 million (2022), compared with a mean of $26.2 million.
  • Biggest five-year swings in Short term Debt: surged 240.69% in 2024 and later tumbled 70.83% in 2025.
  • Bioventus' Short term Debt stood at $18.0 million in 2021, then soared by 83.26% to $33.1 million in 2022, then plummeted by 40.76% to $19.6 million in 2023, then surged by 39.6% to $27.3 million in 2024, then plummeted by 58.85% to $11.2 million in 2025.
  • The last three reported values for Short term Debt were $11.2 million (Q3 2025), $43.4 million (Q2 2025), and $37.3 million (Q1 2025) per Business Quant data.